An autistic Alabama patient was the center of a recent lawsuit in Philadelphia, which ended in late February with the patient being awarded $2.5 million in damages. The patient, now an adult, took the medication as a child for treatment of ADHD, or Attention Deficit Hyperactivity Disorder. Johnson & Johnson’s Jannsen Pharmaceuticals runs their Risperdal division and the companies now have numerous lawsuits to contend with. They previously settled criminal and civil charges brought against...